Your browser doesn't support javascript.
loading
Safety and efficacy of nazartinib (EGF816) in adults with EGFR-mutant non-small-cell lung carcinoma: a multicentre, open-label, phase 1 study.
Tan, Daniel S-W; Leighl, Natasha B; Riely, Gregory J; Yang, James C-H; Sequist, Lecia V; Wolf, Juergen; Seto, Takashi; Felip, Enriqueta; Aix, Santiago P; Jonnaert, Maud; Pan, Chun; Tan, Eugene Y; Ko, Jinnie; Moody, Susan E; Kim, Dong-Wan.
Afiliação
  • Tan DS; Division of Medical Oncology, National Cancer Centre Singapore, Singapore. Electronic address: daniel.tan.s.w@singhealth.com.sg.
  • Leighl NB; Department of Medicine, Princess Margaret Hospital, Toronto, ON, Canada.
  • Riely GJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Yang JC; Department of Oncology, National Taiwan University Hospital and National Taiwan University, Taipei, Taiwan.
  • Sequist LV; Center for Innovation in Early Cancer Detection, Massachusetts General Hospital, Boston, MA, USA.
  • Wolf J; Department of Internal Medicine, Center for Integrated Oncology, University Hospital Cologne, Cologne, Germany.
  • Seto T; Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan.
  • Felip E; Department of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Aix SP; Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain.
  • Jonnaert M; Novartis Pharma AG, Basel, Switzerland.
  • Pan C; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Tan EY; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Ko J; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Moody SE; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Kim DW; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
Lancet Respir Med ; 8(6): 561-572, 2020 06.
Article em En | MEDLINE | ID: mdl-31954624
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Benzimidazóis / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Nicotina / Antineoplásicos Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Respir Med Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Benzimidazóis / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Nicotina / Antineoplásicos Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Respir Med Ano de publicação: 2020 Tipo de documento: Article